Sfoglia per RIVISTA
VACCINE
Collezione AOU Novara

  

Items : 4

Corrigendum to "Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial" [Vaccine 35 (2017) 395-402]. in Vaccine / Vaccine. 2017 May 31;35(24):3279. doi: 10.1016/j.vaccine.2017.04.081. Epub 2017 May 5.

2017
AOU Novara

Iro MA; Snape MD; Voysey M; Jawad S; Finn A; Heath PT; Bona G; Esposito S; Diez-Domingo J; Prymula R; Odueyungbo A; Toneatto D; Dull P; Pollard AJ;

Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial. in Vaccine / Vaccine. 2017 Jan 5;35(2):395-402. doi: 10.1016/j.vaccine.2016.11.009. Epub 2016 Nov 30.

2017
AOU Novara

Iro MA; Snape MD; Voysey M; Jawad S; Finn A; Heath PT; Bona G; Esposito S; Diez-Domingo J; Prymula R; Odueyungbo A; Toneatto D; Dull P; Pollard AJ;

Safety and immunogenicity of a CRM or TT conjugated meningococcal vaccine in healthy toddlers. in Vaccine / Vaccine. 2016 Jun 17;34(29):3363-70. doi: 10.1016/j.vaccine.2016.05.009. Epub 2016 May 12.

2016
AOU Novara

Bona G; Castiglia P; Zoppi G; de Martino M; Tasciotti A; D'Agostino D; Han L; Smolenov I;

The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy. in Vaccine / Vaccine. 2016 Aug 5;34(36):4278-84. doi: 10.1016/j.vaccine.2016.07.009. Epub 2016 Jul 14.

2016
ASL Cuneo 1
AOU Novara

Povey M; Marchetti F; Salvini F; Pellegrino A; Gabutti G; Cuccia M; Desole MG; Ferrera G; Esposito S; Bona G; Henry O; Durando P;